To determine whether changes in pulse wave velocity predict hypotension during dialysis

ISRCTN ISRCTN12870218
DOI https://doi.org/10.1186/ISRCTN12870218
Secondary identifying numbers protocol version 4
Submission date
11/10/2013
Registration date
01/11/2013
Last edited
17/01/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Low blood pressure is the most common complication for patients attending for routine outpatient haemodialysis treatments (filtering out waste products from the blood). Low blood pressure could be due to too low a blood volume, but could also be due to relaxation of the blood vessels. We wish to measure blood pressure during dialysis with a more sophisticated blood pressure machine that provides information about the stiffness of the major arteries to see whether there is relaxation of these arteries occurring before a fall in blood pressure.

Who can participate?
Patients with long-term kidney disease who are treated by regular outpatient haemodialysis in the Royal Free Hospital can participate in the study.

What does the study involve ?
When patients come for haemodialysis we will use a standard blood pressure cuff placed on the upper arm which is linked to a blood pressure machine and a computer that can measure pulse wave velocity. This equipment is currently used in routine clinical practice. The only difference compared to a standard blood pressure machine is that the blood pressure cuff inflates three times. As with standard practice, blood pressure will be measured before dialysis, at 20 minutes, then hourly. If you have not had a recent electrical recording of the heart (ECG) we will perform one.

What are the possible benefits and risks of participating?
There may be no immediate benefits to any patient. No additional blood tests are required, and the blood pressure test is non-invasive and does not cause pain and is performed whilst patients are having dialysis. Similarly if an ECG is recorded, this is painless and can be done during the dialysis treatment.

Where is the study run from?
The study is run from the UCL Centre for Nephrology at the Royal Free Hospital, UK.

When is study starting and how long is it expected to run for?
The study starts in January 2013 is expected to end in late 2014.

Who is funding the study?
The study is funded by the Royal Free Hospital, UK.

Who is the main contact?
Dr Andrew Davenport
andrewdavenport@nhs.net

Contact information

Dr Andrew Davenport
Scientific

UCL Centre for Nephrology
Royal Free Hospital
Pond St
London
NW3 2QG
United Kingdom

Study information

Study designProspective cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet ISRCTN12870218_PIS_09Aug12_V4.doc
Scientific titleStudy to determine whether changes in pulse wave velocity are associated with changes in blood pressure in haemodialysis patients
Study objectivesDo changes in major arterial compliance occur during haemodialysis and does this lead to low blood pressure during haemodialysis?
Ethics approval(s)London Central Ethics Committee, 05/09/2012, ref: 12/LO/0976
Health condition(s) or problem(s) studiedHaemodialysis
InterventionAll participants have a blood pressure cuff placed around their non fistula arm. Blood pressure measurements are taken three times spaced three minutes apart, during which time pulse wave velocity measurements are taken.
Post-dialysis, medical records are reviewed to see if there is any relationship to the changes of blood pressure during dialysis.
Intervention typeOther
Primary outcome measureBlood pressure and pulse wave velocity are measured using a blood pressure cuff.
Blood pressure will be measured at the start of a dialysis session, then at 20 minutes, one hour and then hourly during the dialysis session. Changes in pulse wave velocity and heartbeat variation will be reviewed to determine whether these are related to changes in blood pressure during the dialysis session.
Secondary outcome measuresDerived variables from pulse wave velocity.
Overall study start date01/01/2013
Completion date31/12/2014

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participantsMore than 100
Key inclusion criteria1. Patients with chronic kidney disease treated by haemodialysis
2. Patients who are able to provide valid consent
3. Patients who can have their blood pressure measured using an arm blood pressure cuff
Key exclusion criteria1. Patients who do not fulfil the inclusion criteria
2. Patients who cannot provide valid informed consent
3. Patients who cannot have their blood pressure measured using an upper arm blood pressure cuff
4. Those with atrial fibrillation and other cardiac arrhythmias
Date of first enrolment01/01/2013
Date of final enrolment31/12/2014

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

UCL Centre for Nephrology
Royal Free Hospital
Pond St
London
NW3 2QG
United Kingdom

Sponsor information

Royal Free Hospital (UK)
Hospital/treatment centre

Pond street
London
NW32QG
England
United Kingdom

ROR logo "ROR" https://ror.org/01ge67z96

Funders

Funder type

Hospital/treatment centre

Royal Free Hospital (UK)

No information available

Results and Publications

Intention to publish date31/12/2013
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planPlanned publication in a peer reviewed journal.
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 08/09/2013 Yes No
Participant information sheet version V4 09/08/2012 17/01/2017 No Yes

Additional files

ISRCTN12870218_PIS_09Aug12_V4.doc
Uploaded 17/01/2017

Editorial Notes

17/01/2017: The participant information sheet has been uploaded and the date of ethical approval has been added.
13/01/2017: Publication reference added.